Portugal vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin
Portugal
54.52
in 2021
Trinidad and Tobago
59.38
in 2021
Portugal rank
112th
Trinidad and Tobago rank
110th
The number of people with susceptibility test result for rifampicin over time
- Portugal
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 59.38 against 54.52 in Portugal, a difference of 4.86.
That makes Trinidad and Tobago's figure about 1.1 times Portugal's.
Across all 5 years both countries report, Trinidad and Tobago has been ahead every year.
Portugal ranks 112th and Trinidad and Tobago ranks 110th of 146 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Portugal | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.49 | 73.58 | 15.09 | Trinidad and Tobago |
| 2020s | 53.61 | 66.49 | 12.87 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Portugal or Trinidad and Tobago?
- Trinidad and Tobago, at 59.38 against 54.52 in Portugal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Portugal and Trinidad and Tobago?
- 4.86, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Portugal and Trinidad and Tobago?
- 5 years are reported by both, from 2017 to 2021.
- How do Portugal and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
- Portugal ranks 112th and Trinidad and Tobago ranks 110th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.